Below you'll find a list of all posts that have been categorized as “Best Practices”
Psychology Tools offers a wealth of new resources for patients and therapists at Gateway Psychiatric. These tools include hundred of worksheets, handouts, exercises, podcasts, and information sheets that are solidly founded in clinical research. The entire collection is searchable by resource type, problem and therapy type and thus easily accessible. Gateway is licensed to share these materials with any patient …
A powerful online assessment that automatically scores a couple’s strengths and challenges. Created by Drs. John and Julie Gottman in collaboration with The Gottman Institute and Affective Software Inc. This clinical tool consists of 337 questions about friendship, intimacy, how well you know your partner, how you manage emotions and conflict, how you share your values and goals, and what …
Three different findings associated with insulin resistance and pre-diabetes are predictive of developing depression according to a study published online from the American Journal of Psychiatry. Study Summary MedPage Today (9/23/2021) writes that, “Three surrogate measures for insulin resistance all showed a significant link with developing a major depressive disorder [MDD] over a nine-year follow-up period,” researchers concluded. The 601-participant study …
Next week will commence another round of our 6 week Bipolar 101 group for Gateway clients/patients hoping to learn more about how to manage the impact of their moods with more grace and awareness. Bipolar 101 is an online, six session group that covers topics such as general knowledge of the disorder, medications, substance use, early detection of episodes, healthy …
One of the questions that has bedevilled clinicians ever since the introduction of the first SSRI (Prozac, fluoxetine) is whether there is any relationship between SSRI doses and effectiveness. In other words, do higher doses result in greater effectiveness. I can recall about 20 years ago reading the first clinical trial looking at this question. It was an article published …
Psychotherapies — particularly cognitive-behavioral approaches used as adjunctive treatments — can play a critical role in helping people with a history of depression avoid relapse. For many people, major depression is a chronic illness. Even when they are no longer depressed, people who have had several episodes of depression have to be concerned about a significant risk of a recurrence …
People with bipolar disorder are much less likely to receive psychotherapy (26-50% of patients in one study got therapy) as opposed to psychiatric medications (46-90% were treated with medications) according to a study sponsored by the Depressive and Bipolar Support Association. This is not surprising since many mental health professionals were taught when we were in training that bipolar depression …
Boadie Dunlop, M.D., M.S., and Helen Mayberg, M.D., both of Emory University School of Medicine, and colleagues assessed resting-state functional connectivity between the subcallosal cingulate cortex (SCC) and three other brain regions—the dorsal midbrain, the ventrolateral prefrontal cortex and anterior insula, and the ventromedial prefrontal cortex—in 122 patients with depression. The patients were then randomized to 12 weeks of cognitive-behavioral …
Although there is reason for optimism about some of the newer medications for insomnia (orexin antagonists) that are coming to market, it remains true that sleeping medications are not the right answer for many people with insomnia. Cognitive behavioral therapy for insomnia (CBTi) has several advantages as an initial treatment. Cognitive Behavioral Therapy for Insomnia First We have been writing …
I have long been a strong proponent of generic medications. Recently, however, several of my patients have expressed concerns about the generic medications that they have received. This led me to do some research on generic pharmaceutical companies. The first thing to know about generics is that they are made by many different manufacturers in many different countries. This is …
